# Business Use Case: Clinical Trial Intelligence & Patient-Trial Matching Platform

## 1. Executive Summary
Clinical trial delays cost pharmaceutical companies between $600,000 and $8 Million per day in lost patent exclusivity and operational overhead. The single largest bottleneck in clinical development is **patient recruitment and site-level enrollment underperformance** (over 80% of clinical trials fail to meet enrollment timelines on schedule, and 50% of sites enroll zero or one patient).

This platform acts as an **intelligent clinical operations and matching engine** that:
1. **Accelerates Patient Screening**: Matches structured/unstructured synthetic EHR patient profiles against trial inclusion/exclusion criteria.
2. **Provides Explainable Eligibility Evidence**: Evaluates each criterion individually, outputting `PASS`, `FAIL`, or `UNKNOWN` (with explicit flags for missing lab or biomarker data).
3. **Forecasts Site Enrollment Risk**: Employs an XGBoost machine learning model to predict site-level enrollment targets and highlight at-risk sites.
4. **Human-in-the-Loop Governance**: Mandatory Clinical Reviewer sign-off on all patient matching recommendations with full auditability.

---

## 2. Target Industry & Organizations
- **Therapeutic Focus**: Clinical Operations (ClinOps), Oncology, Immunology, Clinical Development.
- **Target Organizations**: Clinical Stage Biopharma Enterprises, Academic Medical Centers, and Contract Research Organizations (CROs).

---

## 3. Current State vs. Target State

| Dimension | Current State (Manual Trial Recruitment) | Target State (Clinical Trial Intelligence Platform) |
| :--- | :--- | :--- |
| **Patient Screening** | Study coordinators manually read 50+ pages of EHR notes per patient to verify 20+ protocol criteria. | Automated multi-agent screening extracting criteria matches in seconds with inspectable supporting snippets. |
| **Criterion Ambiguity** | Subjective clinician interpretation leading to protocol deviations or inappropriate screening failures. | Strict criterion-by-criterion status (`PASS` / `FAIL` / `UNKNOWN`) with missing data checklist. |
| **Site Risk Management** | Site recruitment targets tracked on static monthly spreadsheets; underperformance detected months late. | Predictive ML forecasting site enrollment trajectory and flagging risk early based on screening velocity and history. |
| **Clinical Decision Governance** | Informal email communications for eligibility decisions; lack of central audit trail. | Role-based clinical review queue (`CLINICAL_REVIEWER`) with immutable audit logging for regulatory inspection. |

---

## 4. Primary Personas & User Journeys

### Persona A: Clinical Trial Coordinator / Research Nurse
- **Pain Point**: "I have 40 oncology patients in my clinic this month. Are any of them eligible for our Phase II Non-Small Cell Lung Cancer (NSCLC) study with EGFR exon 20 mutations?"
- **User Journey**:
  1. Searches patient cohort or opens patient profile (e.g., `Patient #PT-4091`).
  2. Triggers matching against active protocol criteria.
  3. Inspects the **Criterion Verification Matrix**:
     - *Age >= 18*: `PASS` (Age: 54)
     - *ECOG Performance 0-1*: `PASS` (ECOG 1 recorded on 2024-03-12)
     - *EGFR Exon 20 Insertion*: `PASS` (Genomic test positive)
     - *Prior anti-PD-1 therapy within 4 weeks*: `FAIL` (Pembrolizumab administered 18 days ago)
  4. System labels overall status: `INELIGIBLE (Failed Exclusion Criterion #4)`.
  5. Coordinator saves dozens of hours of futile pre-screening.

### Persona B: Clinical Operations Manager (Study Lead)
- **Pain Point**: "Which of our 60 trial sites are going to miss their Q3 enrollment targets, and why?"
- **User Journey**:
  1. Opens **Site Performance & Risk Dashboard**.
  2. XGBoost model forecasts enrollment trajectories against planned curves.
  3. Filters for `High Risk Sites` (e.g., *Memorial University Site*).
  4. NL2SQL query runs: *"Show screening velocity, screen failure rate, and dropout count for Site #14."*
  5. Identifies screen failure bottleneck in imaging turnaround; allocates mobile imaging unit to rescue site.

---

## 5. Agentic AI & NL2SQL Architecture

- **Safe NL2SQL**: Enables ClinOps leads to query trials, patient cohorts, and site telemetry with questions like:
  *"List all trials in Phase III Oncology with open recruitment across North America having enrollment gap > 20%."*
- **LangGraph Multi-Agent Team**:
  - `Patient Profile Agent`: Parses synthetic patient demographics, diagnoses, and lab values.
  - `Trial Protocol Agent`: Decomposes inclusion/exclusion criteria.
  - `Eligibility Reasoning Agent`: Checks deterministic bounds (age, lab thresholds) and semantic criteria via Sarvam AI.
  - `Human Review Gate`: Prevents automatic status approval without reviewer sign-off.

---

## 6. Measurable Business KPIs & Financial ROI

- **Recruitment Acceleration**: 50% reduction in patient pre-screening time.
- **Trial Timeline Preservation**: Early detection of failing sites prevents 4–6 week trial enrollment delays (saving ~$1.5M+ in study rescue costs).
- **Protocol Compliance**: 99% reduction in protocol deviations related to eligibility criteria screening.
